T cell responses to an HLA-A2-restricted adipophilin peptide correlate with BMI in patients with atherosclerosis

Physiology International
K KalantarM Doroudchi

Abstract

Atherosclerosis is an inflammatory disease causing a vast array of cardiovascular diseases. Adipophilin has been reported to be highly expressed in atherosclerotic lesions. This study investigated the possible existence of auto-reactive T cells against an HLA-A02-restricted adipophilin-derived peptide as well as peptides from Epstein-barr virus (EBV), Cytomegalovirus (CMV) and influenza (Flu) virus in patients with atherosclerosis. HLA-A02 expression on peripheral blood mononuclear cells (PBMCs) was examined by flow cytometry. PBMCs from HLA-A02 individuals were stimulated with adipophilin, CMV, EBV, and Flu peptides at a concentration of 10 µM. Interferon (IFN)-γ production was evaluated in the culture supernatant using a commercial ELISA test. The levels of IFN-γ production against an HLA-A02-restricted adipophilin peptide and peptides from CMV, EBV, and Flu revealed no statistically significant differences between patients and healthy controls. However, we found a positive correlation between IFN-γ production against adipophilin and Body mass index (BMI) of patients (R = 0.8, P = 0.003), whereas no significant correlation was found in healthy controls (R = -0.267, P = 0.378). No correlation between BMI and IFN-γ production a...Continue Reading

References

Oct 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J L MelnickM E DeBakey
Apr 1, 1996·Scandinavian Journal of Immunology·R WuA K Lefvert
Jun 1, 1997·The Journal of Clinical Investigation·S GuptaC Schindler
Jul 3, 2002·Nature Reviews. Immunology·Michele Barry, R Chris Bleackley
Dec 6, 2003·Transplantation·Suzanne Fateh-MoghadamMeinrad Gawaz
Dec 2, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ali I IbrahimBarbara C Gärtner
Dec 1, 2007·Stroke; a Journal of Cerebral Circulation·Tymen T KellerOnno J de Boer
Feb 5, 2008·Journal of Immunological Methods·Emanuela MartinuzziRoberto Mallone
Apr 12, 2008·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Edyta ReszkaRyszard Jaszewski
Jun 24, 2008·Inflammation·Xiu-Ru GuanHong-Yuan Li
Aug 19, 2008·Human Pathology·Jan GewaltigBarbara C Biedermann
Oct 18, 2008·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Li YiZi-Jing Feng
Dec 4, 2008·Journal of Lipid Research·Ziad MallatAlain Tedgui
Mar 19, 2009·Coronary Artery Disease·Concetta IraceAgostino Gnasso
Mar 24, 2009·Annual Review of Immunology·Elena Galkina, Klaus Ley
Jul 29, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·John AnderssonGöran K Hansson
Jul 28, 2010·American Journal of Epidemiology·Eric T RobertsAllison E Aiello
Sep 18, 2010·Mediators of Inflammation·Zhaoxia Wang, Tomohiro Nakayama
Jun 26, 2012·International Journal of Cardiology·Daniela PedicinoGiovanna Liuzzo
May 15, 2013·Clinical Science·Kevin J Woollard
Aug 7, 2013·Trends in Cardiovascular Medicine·Iryna VoloshynaAllison B Reiss
Jul 18, 2014·World Journal of Clinical Cases·Rosa SessaOmbretta Turriziani
May 26, 2015·Archives of Medical Research·Lee Ann Campbell, Michael E Rosenfeld

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.